1 JDRF Type One Nation Research Summit Diabetes Technology: A Bridge to a Cure Kelly L. Close, president, Close Concerns editor-in-chief, diatribe March 1, 2014 closeconcerns.com Slide 1
2 We thank many researchers, scientists + funders
3 Outline About Us A snapshot of new and upcoming diabetes technology The artificial pancreas UVA s overnight closed-loop system The future of diabetes technology Slide 3
4 Outline About Us A snapshot of new and upcoming diabetes technology The artificial pancreas MGH / BU UVA s overnight closed-loop system The future of diabetes technology
5 About Us Close Concerns: founded in 2002 as a healthcare information company focused exclusively on diabetes Our mission: to improve patient outcomes by making everyone smarter about diabetes and obesity Providing a platform for young healthcare leaders is also incredibly important to us.
7 About Us diatribe: founded in 2006, a website for patient education. Our mission is to help people with diabetes become healthier and happier through education. diatribe is a non-profit supported by the Helmsley Charitable Trust and many others. Over 100,000 readers have visited the diatribe website over the last 18 months (www.diatribe.org)
8 Slide 8
9 About Us dq&a dq&a: founded in 2009, a market research company focused on diabetes and obesity. The mission is to help the diabetes industry understand the true voice of the patient and their healthcare team. dq&a works with a panel of 12,000 patients, interviewing them quarterly (now for 18 straight quarters). Also works with panels of educators and physicians, and provides custom research.
10 Outline About Us A snapshot of new and upcoming diabetes technology The artificial pancreas UVa s overnight closed-loop system The future of diabetes technology
11 Living with diabetes can and should provide you with the opportunity to celebrate a full, active, and wonderful life. The tools and resources available for you to care for your diabetes in the midst of a busy, productive and fulfilling life are better today than at any time in the modern history of diabetes care. -Dr. David Kendall, Eli Lilly, Indianapolis, IN
12 A1c necessary but not sufficient A seven-center, 21-day CGM study found that: People with type 1 diabetes were found to be in the optimal ADA glycemic zone only 28% of the time, on average spending over 2 hours/day in hypoglycemia Source: Dr. Bruce Bode, Diabetes Care, 2005 Glycemic Characteristics in Continuously Monitored Patients with Type 1 and Type 2 Diabetes
13 Why A1c does not tell the full story... An A1c of 7% = average of 154 mg/dl Range Example 1 < 70 mg/dl 8% mg/dl 63% > 180 mg/dl 29% Approximate A1c 7.0% Example 2 24% 18% 58% 7.0% Example 3-100% - 7.0% But time in range and thus quality of A1c can be drastically different! Source: the diatribe Foundation
14 Example 1 A1c of 7%
15 Example 2 A1c of 7%
16 Example 3 A1c of 7%
17 Medtronic MiniMed 530G (Enlite/Veo) FDA approved in late September 2013
18 Insulet s New OmniPod Launched in % smaller, 16% slimmer vs. old OmniPod New LifeScan Verio BGM handheld just submitted to FDA Working on combined pod/cgm integration
19 Telcare cellular-enabled blood glucose meter Wireless blood glucose monitor that automatically uploads results online Source: Close Concerns, Inc.
20 LifeScan OneTouch Verio Sync App and meter just launched in January. Wireless (Bluetooth) Source: Close Concerns, Inc.
21 Glooko MeterSync Cable/Web Platform Available for iphone and Android; compatible with 29 meters Working on Bluetooth version Source: Close Concerns, Inc.
22 Dexcom Share (remote monitoring) Under FDA review; potential 2014 launch Wireless Dexcom G4 Receiver + Docking Station CGM data sent to up to five followers smartphones Source: Close Concerns, Inc.
23 Animas Vibe with Dexcom G4 Platinum integration Under FDA review; potential launch in late 2014 Source: Close Concerns, Inc.
24 Tandem t:slim with Dexcom G4 Platinum integration Potential launch in late 2014/2015. Not yet submitted to FDA. Dual-chamber pump in development. Source: Close Concerns, Inc.
25 Medtronic MiniMed 640G (predictive suspend) European launch by October 31, 2014; no US timeline Predictive low glucose suspend much more effective than threshold suspend New pump platform and user interface New Enlite 2 CGM sensor Source: Close Concerns, Inc.
26 Outline About Us A snapshot of new and upcoming diabetes technology The bionic pancreas UVa s overnight closed-loop system The future of diabetes technology
27 A control algorithm running on an iphone
28 Two Tandem pumps + Dexcom G4 CGM
29 Dr. Ed Damiano (Boston University) Beacon Hill Study (amazing) 5 days of wear in 3 square-mile area Eat and exercise as wanted Average BG: 133 mg/dl, <1.5% <60 mg/dl Dr. Damiano s Timeline 2013: Beacon Hill, summer camp 2014: 12-day multi-center study 2014: Pre-adolescent summer camp ~2015/16: Pivotal study ~2017: Commercial launch Source: Close Concerns, Inc.
30 Amazing glucose control
31 I felt like a whole new Kelly
32 Outline About Us A snapshot of new and upcoming diabetes technology The artificial pancreas UVa s overnight closed-loop system The future of diabetes technology
33 UVa s Overnight Closed-Loop System Five nights in a research house. Dexcom CGM, smartphone controller, Roche pump
34 UVa s Overnight Closed-Loop System CLOSED-LOOP ON The control algorithm adjusts insulin delivery from 11pm-7am to target 120 mg/dl
35 Some of my learnings Overnight closed-loop worked WAY better than I can do on my own, and was much safer My insulin requirements vary A LOT from night to night Diabetes disrupts sleep OFTEN! Great nighttime glucose control even improved my blood sugars the next day starting every morning at 120 mg/dl is pretty powerful.
36 Where Are We Right Now with the Closed Loop? 70%+ time in target during day Excellent overnight control (often 90%+) Outpatient trials Strong algorithms, constant improvement Remote monitoring and portable systems
37 A successful system looms large, but challenges aren t for the faint of heart Optimal device development/ communication Faster insulin / Stable glucagon (chronic use) Reimbursement Regulatory (FDA/EU) requirements/commerci alization
38 Artificial Pancreas: Fully Closed Loop/Dual Hormone Upside Guaranteed <7% A1c Huge patient demand Better reimbursement? Entry barriers Disruptive technology (opportunity to take market share) Roadblocks Unpredictable regulatory environment Speed of insulin (meals) Other hormones/ dual-chamber pump Reliability/safety of CGM Portability Slide 38
39 Other Artificial Pancreas systems: Hybrid Closed Loop Predictive low glucose suspend Predictive CGM trend forecasting Treat-to-range control Automated basal control (bolus at mealtime) Impact (primarily on type 1) More focus on time in zone Improvement in time in zone and likely A1c A decline in hypoglycemia and severe hypoglycemia Pumps/CGMs increasingly becoming standard of care in newly diagnosed type 1s Achievable meaningful increased quality of life Slide 39
40 Outline About Us A snapshot of new and upcoming diabetes technology The artificial pancreas UVa s overnight closed-loop system The future of diabetes technology
41 I look forward to a future where devices are more integrated into my daily life hypoglycemia and hyperglycemia are much less frequent better management doesn t mean more burden an d hassle I don t have to think about diabetes as much!
42 I look forward to a future where Devices are more integrated into my daily life Hypoglycemia and hyperglycemia are less frequent Better management doesn t mean more burden/hassle I don t have to think about diabetes as much! Slide 42
43 Slide 43
44 Sign up for our free patient newsletter at Write to give views to academia/industry THANK YOU JDRF GREATER C&P! Slide 44
AACE/ACE Consensus Statement George Grunberger, MD, FACP, FACE (Chair) 1,2 ; Jill M. Abelseth, MD, FACE 3 ; Timothy S. Bailey, MD, FACP, FACE, ECNU 4,5 ; Bruce W. Bode, MD, FACE 6,7 ; Yehuda Handelsman,
Clinical Trials: What You Need to Know Clinical trials are studies in which people volunteer to test new drugs or devices. Doctors use clinical trials to learn whether a new treatment works and is safe
Evidence: Helping people help themselves A review of the evidence considering whether it is worthwhile to support self-management May 2011 Identify Innovate Demonstrate Encourage Author Dr Debra de Silva
Introduction.... 1 Emerging Trends and Technologies... 3 The Changing Landscape... 4 The Impact of New Technologies... 8 Cloud... 9 Mobile... 10 Social Media... 13 Big Data... 16 Technology Challenges...
Is Connectivity A Human Right? For almost ten years, Facebook has been on a mission to make the world more open and connected. For us, that means the entire world not just the richest, most developed countries.
Poll Results - TIME Mobility Poll, in cooperation with Qualcomm Timing: Quantitative Online Survey: June 29 July 28, 12 Quantitative Phone Survey: July 10 July 25, 12 Audiences: Geographies and Methodology:
Improving General Practice PHASE 1 REPORT March 2014 IMPROVING GENERAL PRACTICE: A CALL TO ACTION PHASE ONE REPORT NHS England INFORMATION READER BOX Directorate Medical Operations Patients and Information
Page 0 of 23 Page 1 of 23 Table of Contents Evaluation Plan Workbook Introduction How to Use this Workbook...2 What is Evaluation?...3 Proving vs. Improving: A Brief History of Evaluation...3 Our Approach...3
Businesses don t buy phone systems for fun. If you re in the market, you re probably responding to an event, such as a move or serious problems with an existing system. Perhaps, you are looking to gain
CANARY BIOTECH & HEALTHCARE INVESTOR ROADSHOW Wednesday 8 July 2015: isonea will be presenting at the Canary Biotech & Healthcare Investor Roadshow to be held on Wednesday 8 th July in Melbourne and Thursday
Avoid these 5 Medication Adherence Pitfalls By Stu Heilsberg, Innovation Principal MEDULLAN, INC. 625 Mount Auburn St., Suite 201 Cambridge, MA 02138 The significance of patient medication adherence has
Focus on your business, not your infrastructure. A buyer s guide to managed infrastructure services. What s in this guide for you? If you re considering managed services as a way of meeting your organization
The Current Ecosystem of Learning Management Systems in Higher Education: Student, Faculty, and IT Perspectives Contents Executive Summary 3 Introduction 5 Findings 8 Conclusion 22 Looking Ahead: Toward
2010 the future of healthcare it s health, then care About the LeAding edge Forum CSC LEADING EDGE FORUM As part of CSC s Offce of Innovation, the Leading Edge Forum (LEF) is a global community whose programs
A REPORT BY HARVARD BUSINESS REVIEW ANALYTIC SERVICES How the Cloud Looks from the Top: Achieving Competitive Advantage In the Age of Cloud Computing Sponsored by Length of Time Using Cloud Computing Figure
What s important to me. A Review of Choice in End of Life Care Published by The Choice in End of Life Care Programme Board February 2015 1 Page About this review The Choice in End of Life Care Programme
A fresh start for the regulation and inspection of adult social care Working together to change how we inspect and regulate adult social care services The Care Quality Commission is the independent regulator
how can we improve the quality of nhs care? how can we meet everyone s healthcare needs? how can we maintain financial sustainability? what must we do to build an excellent nhs now & for future generations?
Annual Report 2014 P E R F O R M A N C E Reporting solid results, Roche will propose an increase of the dividend for the 28 th year running. Discover how the new Chairman, Christoph Franz, plans to build
HEALTH + SOCIAL SERVICES SMARTER SMALL BUSINESS REPORT Top tips you can t afford to miss CONTENTS 4 6 8 10 11 12 14 15 UNDER PRESSURE: AUSTRALIA S HEALTHCARE SECTOR IMPROVE YOUR PATIENTS EXPERIENCE PROTECT
Drug Discovery and Development UNDERSTANDING THE R&D PROCESS This is a fantastic time to be doing drug discovery. We have an incredible wealth of knowledge that has been generated over the past few years.
Growth Services Selling Power: Better Sales Leads and Conversion Rates in a 360-Degree World Better Sales Leads and Conversion Rates in a 360-Degree World THE LEADERSHIP CHALLENGE: A WEALTH OF DATA Today,
ACCESS CONNECT INFORM PROTECT Patients First: Action Plan for Health Care February 2015 Ministry of Health and Long-Term Care Office of the Minister 10 th Floor, Hepburn Block 80 Grosvenor Street Toronto